US 11,654,174 B2
Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection
Weiwei Su, Guangdong (CN); Chong Liu, Guangdong (CN); Qian Zhou, Guangdong (CN); Peibo Li, Guangdong (CN); Wei Peng, Guangdong (CN); and Yonggang Wang, Guangdong (CN)
Assigned to SUN YAT-SEN UNIVERSITY, Guangzhou (CN)
Filed by SUN YAT-SEN UNIVERSITY, Guangdong (CN)
Filed on Oct. 6, 2021, as Appl. No. 17/494,850.
Application 17/129,885 is a division of application No. 15/920,480, filed on Mar. 14, 2018, granted, now 11,154,582.
Application 17/494,850 is a continuation of application No. 17/129,885, filed on Dec. 21, 2020, abandoned.
Application 15/920,480 is a continuation of application No. PCT/CN2017/071671, filed on Jan. 19, 2017.
Claims priority of application No. 201610308207.4 (CN), filed on May 10, 2016; application No. 201610308716.7 (CN), filed on May 10, 2016; application No. 201610308717.1 (CN), filed on May 10, 2016; and application No. 201610308718.6 (CN), filed on May 10, 2016.
Prior Publication US 2022/0023369 A1, Jan. 27, 2022
Int. Cl. A61K 36/48 (2006.01)
CPC A61K 36/48 (2013.01) [A61K 2236/331 (2013.01); Y02A 50/30 (2018.01)] 3 Claims
1. A method of treating a disease caused by an Extended-Spectrum Beta-Lactamase producing Escherichia Coli infection, comprising administering a Pithecellobium clypearia Benth Extract (EA) in combination with at least one antibiotic selected from the group consisting of Amikacin and Sulfamethoxazole, wherein the EA is a water extract or ethanol extract.